Posted by Michael Wonder on 03 Mar 2023
Bipartisan senators introduce bill to close pharma competition loophole
1 March 2023 - Senators Maggie Hassan and Mike Braun on Wednesday reintroduced legislation intended to close a loophole that drug companies can exploit to block competition, including from lower-cost generic drugs.
Federal regulators will sometimes require that drug manufacturers have a Risk Evaluation and Mitigation Strategy (REMS) program for potentially dangerous medications.
